ICI Grant Programs

Quick Overview

ICI Core Grants support and test novel bioinformatics applications in cancer aimed at clinical impact. These grants may enable cancer researchers to develop data on the efficacy of their approach that may, in turn, enable them to obtain additional funding from the National Cancer Institute (NCI), National Science Foundation (NSF), or other research foundations supporting cancer research.

• Major Grant Awards support 1 to 2-year projects at up to $100,000 a year. ICI allows indirect costs of up to 12% for a total possible grant of $112,000.
• Discovery Grants of $25,000 are occasionally awarded to projects of interest but need more proof of concept.
• Proposals are required to include yearly milestones for the purpose of evaluating progress toward overall project goals. These milestones must be achieved in order to qualify for the second year of funding.
• Projects should be focused on clinical impact.
• Projects should focus on the use of existing data. Data generation should not be the primary focus of the proposal
• Projects are strongly encouraged to have a clinician on the team to manage clinical application and use.
• Proposals are typically from a single institution. However, this is not required.

Learn More and Apply

Upcoming Deadlines

• Spring 2022: March 11, 2022

Quick Overview

This grant opportunity was created based on feedback received during the November 2019 ICI Summit that brought together 32 national leaders in cancer informatics tasked with the singular objective of helping ICI choose its first multi-year, multi-institutional collaborative investment. This effort was led by ICI Advisor, Chris Sander of Dana-Faber and a committee including ICI Advisors: Bob Grossman, Channing Paller, and Niki Schultz, as well as outside advisors: Zak Kohane, Susanne Churchill, Meromit Singer, and Søren Brunak.

These larger grants are focused on fostering collaboration between tool builders and tool users on decision support projects involving two or more institutions to achieve near term clinical impact. The goal is to dramatically accelerate improvements in clinical decision making, care, and outcomes for cancer patients in 36 months or less.

• One or more multi-institutional awards that support investigator-initiated projects for 1 to 3 years@ 200K per institution/per year (contact program office for larger proposals). This email address is being protected from spambots. You need JavaScript enabled to view it.
• If data standardization, curation, integration, or related tools are needed, these can be included in the proposals.
• Multi-year proposals should include yearly milestones for the purpose of evaluating progress toward overall project goals. These milestones must be achieved in order to qualify for the following year of funding.
• For 3-year projects: by year 2 the project should be in its testing phase, and by year 3 the project should be in implementation.
• Projects should have a high probability of leading to near-term clinical impact in 3 years or less
• Projects should focus on the use of existing data. Data generation should not be the primary focus of the proposal
• Minimum of two institutions and two Principal Investigators at each institution.
• Each team is required to have a clinician member at each institution to manage clinical application and use.

Learn More and Apply

Upcoming Deadlines

Opening Round 2021 Deadlines:

• Pre-application: Friday, April 16, 2021
• Full Application: Friday, September 17, 2021